In summary, our data demonstrate that PGC-1α ameliorates hepatic steatosis and hinders progression to steatohepatitis, possibly via the SIRT2-PGC-1α-NAD+ feedback loop (Fig. 7). This evidence concerns the gene PPARGC1A and fatty liver disease.